Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 271

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 271
---
 of public shares redeemed by holders in connection with a Business Combination. 
 The following table presents the deferred underwriting commission as a percentage of the             
 cash left in the Trust Account following redemptions across a range of varying redemption            
 scenarios.                                                                                           |

Sources and Uses of Funds for
the Business Combination

The following
table summarizes the sources and uses for funding the Business Combination. These figures assume (i) that no public stockholders exercise
their redemption rights in connection with the Business Combination, or alternatively, that all public stockholders exercise their redemption
rights in connection with the Business Combination, and (ii) that FutureTech issues 9,217,200 shares of FutureTech Common Stock to the
Existing Longevity Stockholders at the Closing as the Merger Consideration. If the actual facts are different from these assumptions,
then the amounts and shares outstanding after the Closing will be different and those changes could be material.

No Redemptions Scenario

|                                                        |     | Sources |             |
|:-------------------------------------------------------|:----|:--------|------------:|
| Cash in Trust(A)                                       |     | $       |  26,538,459 |
| Due from Sponsor                                       |     |         |     809,072 |
| Longevity Equity Rollover(B)                           |     |         | 100,000,000 |
| PIPE Investment                                        |     |         |   5,000,000 |
| Cash in FutureTech & Longevity Operating Bank Accounts |     |         |     673,612 |
| Total Sources                                          |     | $       | 133,021,143 |

|                                   |     | Uses |             |
|:----------------------------------|:----|:-----|------------:|
| Cash to FutureTech Balance Sheet  |     | $    |  12,343,690 |
| Longevity Equity Rollover(B)      |     |      | 100,000,000 |
| Redemptions to be paid(C)         |     |      |  18,032,453 |
| Estimated Transaction Expense(D). |     |      |   2,645,000 |
| Total Uses                        |     | $    | 133,021,143 |

| (B) | Reflects the issuance of 9,217,200 shares of FutureTech Common Stock to the Existing Longevity |

| (C) | Reflects the reduction from the Trust Account of the redemptions to be made in connection with the Third